Drug Regulation Critical To Addressing TB, Antimicrobial Resistance

PLOS Blogs’ “Speaking of Medicine”: Drug Regulation in the Age of AMR — What We Know from our Experience with Tuberculosis
“On the eve of the Union World Conference on Lung Health, [Bev Stringer, who leads the social science research and program support team at Médecins Sans Frontières,] discusses how unregulated access to anti-tuberculosis treatments has contributed to the rise of multidrug-resistant TB…” (10/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.